Gm1-Gangliosidosis, Type I (GM1G1)

Gm1-Gangliosidosis, Type I(来自ICD-11)
别称:
Beta-Galactosidase-1 Deficiency
Infantile Gm1 Gangliosidosis
Gm1 Gangliosidosis Type 1
Gangliosidosis, Generalized Gm1, Type 1
Norman-Landing Disease
Glb1 Deficiency
Gm1g1
Gangliosidosis, Generalized Gm1, Infantile Form
Gangliosidosis Generalized Gm1 Infantile Type
Gangliosidosis, Generalized Gm1, Type I
Gangliosidosis Generalized Gm1 Type 1
Beta Galactosidase 1 Deficiency
Beta-Galactosidase Deficiency
Gm1-Gangliosidosis Infantile
Gangliosidosis Gm1 Infantile
Gangliosidosis, Gm1, Type I
Gm1-Gangliosidosis 1
Gangliosidosis Gm1
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Gm1-Gangliosidosis, Type I, also known as beta-galactosidase-1 deficiency, is related to gm1 gangliosidosis and gm1-gangliosidosis, type ii, and has symptoms including joint stiffness An important gene associated with Gm1-Gangliosidosis, Type I is GLB1 (Galactosidase Beta 1), and among its related pathways/superpathways is Degradation pathway of sphingolipids, including diseases. The drugs Miglustat and Glycoside Hydrolase Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include bone and spinal cord, and related phenotypes are decreased beta-galactosidase activity and intellectual disability
查看原文 参与反馈
相关ID:

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Newborn
--
8
47
137

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top